Do no harm - re-evaluating the risks of overtreatment in community-wide tuberculosis screening Article Swipe
Rein M G J Houben
,
Lara D Veeken
,
Alvaro Schwalb
,
Daniel Grint
,
Sean Wasserman
,
Reinout van Crevel
,
Katherine C. Horton
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1101/2025.09.18.25335917
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1101/2025.09.18.25335917
Background Community-wide screening is a crucial strategy to end tuberculosis (TB), but a common concern is potential harm from overtreatment following false positive diagnoses. However, current reference standards determining test performance have limitations, with implications for prevalence thresholds and treatment decisions for community-wide screening. Methods We estimated coverage of community-wide screening at a prevalence threshold of 0.5% (current global standard), 0.25%, and 0.1% for adult pulmonary TB. We considered test performance for Xpert Ultra against different reference standards (sputum culture, plus clinical evaluation, plus disease progression within two years). Potential harm was estimated through disability adjusted life years (DALYs) incurred or averted by treatment. We report net specificity, positive predictive value (PPV), the ratio of false positives to true positives, and DALYs averted for (non-)treatment based on different reference standards. Results A lower threshold would increase screening coverage from the current 42% to 84% (0.25% threshold) and 89% (0.1% threshold) of the global TB burden. In a population of 100,000 with 0.5% prevalence, specificity was 99.5% for community screening, but increased to 99.7% using disease progression as reference standard, with PPV increasing from 45 to 66%. In addition, estimated harm of withholding appropriate treatment was approximately 1,200 times higher compared to providing inappropriate treatment, with treatment initiation after a positive Xpert Ultra increasing overall DALYs averted (median 5,977 versus 3,750). Discussion The benefit of TB treatment following a positive molecular test in community-wide screening likely outweighs the harm associated with possible overtreatment, supporting expanding coverage of simplified community-wide screening. Brief summary A concern with community-wide tuberculosis screening is the potential for overtreatment. We evaluated diagnostic reference standards and relative health costs of (non-)treatment, finding that after a positive molecular test, the benefit of initiating tuberculosis treatment likely outweighs its harm.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1101/2025.09.18.25335917
- https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdf
- OA Status
- green
- References
- 29
- OpenAlex ID
- https://openalex.org/W4414342415
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414342415Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1101/2025.09.18.25335917Digital Object Identifier
- Title
-
Do no harm - re-evaluating the risks of overtreatment in community-wide tuberculosis screeningWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-19Full publication date if available
- Authors
-
Rein M G J Houben, Lara D Veeken, Alvaro Schwalb, Daniel Grint, Sean Wasserman, Reinout van Crevel, Katherine C. HortonList of authors in order
- Landing page
-
https://doi.org/10.1101/2025.09.18.25335917Publisher landing page
- PDF URL
-
https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
29Number of works referenced by this work
Full payload
| id | https://openalex.org/W4414342415 |
|---|---|
| doi | https://doi.org/10.1101/2025.09.18.25335917 |
| ids.doi | https://doi.org/10.1101/2025.09.18.25335917 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41001492 |
| ids.openalex | https://openalex.org/W4414342415 |
| fwci | |
| type | preprint |
| title | Do no harm - re-evaluating the risks of overtreatment in community-wide tuberculosis screening |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10038 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9965000152587891 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Tuberculosis Research and Epidemiology |
| topics[1].id | https://openalex.org/T12578 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9269000291824341 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Diagnosis and treatment of tuberculosis |
| topics[2].id | https://openalex.org/T10833 |
| topics[2].field.id | https://openalex.org/fields/33 |
| topics[2].field.display_name | Social Sciences |
| topics[2].score | 0.9129999876022339 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3306 |
| topics[2].subfield.display_name | Health |
| topics[2].display_name | Vaccine Coverage and Hesitancy |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1101/2025.09.18.25335917 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402567 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| locations[0].source.host_organization | https://openalex.org/I2750212522 |
| locations[0].source.host_organization_name | Cold Spring Harbor Laboratory |
| locations[0].source.host_organization_lineage | https://openalex.org/I2750212522 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1101/2025.09.18.25335917 |
| locations[1].id | pmid:41001492 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | medRxiv : the preprint server for health sciences |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41001492 |
| locations[2].id | pmh:oai:europepmc.org:11267202 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12458509 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5077644295 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4132-7467 |
| authorships[0].author.display_name | Rein M G J Houben |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210089966 |
| authorships[0].affiliations[0].raw_affiliation_string | London School of Hygiene and Tropical Medicine |
| authorships[0].institutions[0].id | https://openalex.org/I4210089966 |
| authorships[0].institutions[0].ror | https://ror.org/00a0jsq62 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I4210089966 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | London School of Hygiene & Tropical Medicine |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Rein Houben |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | London School of Hygiene and Tropical Medicine |
| authorships[1].author.id | https://openalex.org/A5102916993 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2230-4884 |
| authorships[1].author.display_name | Lara D Veeken |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949 |
| authorships[1].affiliations[0].raw_affiliation_string | Radboud University Medical Centre |
| authorships[1].institutions[0].id | https://openalex.org/I2802934949 |
| authorships[1].institutions[0].ror | https://ror.org/05wg1m734 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2802934949 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | Radboud University Medical Center |
| authorships[1].institutions[1].id | https://openalex.org/I145872427 |
| authorships[1].institutions[1].ror | https://ror.org/016xsfp80 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I145872427 |
| authorships[1].institutions[1].country_code | NL |
| authorships[1].institutions[1].display_name | Radboud University Nijmegen |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Lara Veeken |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Radboud University Medical Centre |
| authorships[2].author.id | https://openalex.org/A5019796356 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6518-9719 |
| authorships[2].author.display_name | Alvaro Schwalb |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210089966 |
| authorships[2].affiliations[0].raw_affiliation_string | London School of Hygiene and Tropical Medicine |
| authorships[2].institutions[0].id | https://openalex.org/I4210089966 |
| authorships[2].institutions[0].ror | https://ror.org/00a0jsq62 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I4210089966 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | London School of Hygiene & Tropical Medicine |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Alvaro Schwalb |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | London School of Hygiene and Tropical Medicine |
| authorships[3].author.id | https://openalex.org/A5004101406 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8001-6544 |
| authorships[3].author.display_name | Daniel Grint |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210089966 |
| authorships[3].affiliations[0].raw_affiliation_string | London School of Hygiene and Tropical Medicine |
| authorships[3].institutions[0].id | https://openalex.org/I4210089966 |
| authorships[3].institutions[0].ror | https://ror.org/00a0jsq62 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I4210089966 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | London School of Hygiene & Tropical Medicine |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Daniel Grint |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | London School of Hygiene and Tropical Medicine |
| authorships[4].author.id | https://openalex.org/A5090394540 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3508-6719 |
| authorships[4].author.display_name | Sean Wasserman |
| authorships[4].countries | GD |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I133879957 |
| authorships[4].affiliations[0].raw_affiliation_string | City St George's University |
| authorships[4].institutions[0].id | https://openalex.org/I133879957 |
| authorships[4].institutions[0].ror | https://ror.org/01m1s6313 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I133879957 |
| authorships[4].institutions[0].country_code | GD |
| authorships[4].institutions[0].display_name | St. George's University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sean Wasserman |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | City St George's University |
| authorships[5].author.id | https://openalex.org/A5025258723 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Reinout van Crevel |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949 |
| authorships[5].affiliations[0].raw_affiliation_string | Radboud University Medical Centre |
| authorships[5].institutions[0].id | https://openalex.org/I2802934949 |
| authorships[5].institutions[0].ror | https://ror.org/05wg1m734 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2802934949 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | Radboud University Medical Center |
| authorships[5].institutions[1].id | https://openalex.org/I145872427 |
| authorships[5].institutions[1].ror | https://ror.org/016xsfp80 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I145872427 |
| authorships[5].institutions[1].country_code | NL |
| authorships[5].institutions[1].display_name | Radboud University Nijmegen |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Reinout van Crevel |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Radboud University Medical Centre |
| authorships[6].author.id | https://openalex.org/A5019959072 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-7542-4065 |
| authorships[6].author.display_name | Katherine C. Horton |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210089966 |
| authorships[6].affiliations[0].raw_affiliation_string | London School of Hygiene and Tropical Medicine |
| authorships[6].institutions[0].id | https://openalex.org/I4210089966 |
| authorships[6].institutions[0].ror | https://ror.org/00a0jsq62 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I4210089966 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | London School of Hygiene & Tropical Medicine |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Katherine Horton |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | London School of Hygiene and Tropical Medicine |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Do no harm - re-evaluating the risks of overtreatment in community-wide tuberculosis screening |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10038 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9965000152587891 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Tuberculosis Research and Epidemiology |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1101/2025.09.18.25335917 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402567 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| best_oa_location.source.host_organization | https://openalex.org/I2750212522 |
| best_oa_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1101/2025.09.18.25335917 |
| primary_location.id | doi:10.1101/2025.09.18.25335917 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402567 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| primary_location.source.host_organization | https://openalex.org/I2750212522 |
| primary_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| primary_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.medrxiv.org/content/medrxiv/early/2025/09/19/2025.09.18.25335917.full.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1101/2025.09.18.25335917 |
| publication_date | 2025-09-19 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4408261109, https://openalex.org/W4297249045, https://openalex.org/W4298412344, https://openalex.org/W4404062316, https://openalex.org/W2979246892, https://openalex.org/W2413136365, https://openalex.org/W4384557485, https://openalex.org/W4408551072, https://openalex.org/W2112022845, https://openalex.org/W4282982145, https://openalex.org/W4408945852, https://openalex.org/W3112267403, https://openalex.org/W4408741999, https://openalex.org/W3166201616, https://openalex.org/W4413113852, https://openalex.org/W4413105231, https://openalex.org/W4414110832, https://openalex.org/W4410514040, https://openalex.org/W3205577681, https://openalex.org/W2158543557, https://openalex.org/W3214641779, https://openalex.org/W1980075079, https://openalex.org/W2138041013, https://openalex.org/W2965192848, https://openalex.org/W3160525395, https://openalex.org/W4389924750, https://openalex.org/W4412436880, https://openalex.org/W4412968117, https://openalex.org/W4411473485 |
| referenced_works_count | 29 |
| abstract_inverted_index.A | 132, 252 |
| abstract_inverted_index.a | 5, 13, 53, 157, 209, 228, 277 |
| abstract_inverted_index.45 | 184 |
| abstract_inverted_index.In | 156, 187 |
| abstract_inverted_index.TB | 154, 225 |
| abstract_inverted_index.We | 46, 68, 105, 263 |
| abstract_inverted_index.as | 177 |
| abstract_inverted_index.at | 52 |
| abstract_inverted_index.by | 103 |
| abstract_inverted_index.in | 232 |
| abstract_inverted_index.is | 4, 16, 258 |
| abstract_inverted_index.of | 49, 56, 115, 151, 159, 191, 224, 246, 272, 283 |
| abstract_inverted_index.on | 127 |
| abstract_inverted_index.or | 101 |
| abstract_inverted_index.to | 8, 118, 143, 172, 185, 201 |
| abstract_inverted_index.42% | 142 |
| abstract_inverted_index.84% | 144 |
| abstract_inverted_index.89% | 148 |
| abstract_inverted_index.PPV | 181 |
| abstract_inverted_index.TB. | 67 |
| abstract_inverted_index.The | 222 |
| abstract_inverted_index.and | 39, 62, 121, 147, 268 |
| abstract_inverted_index.but | 12, 170 |
| abstract_inverted_index.end | 9 |
| abstract_inverted_index.for | 36, 42, 64, 72, 124, 167, 261 |
| abstract_inverted_index.its | 289 |
| abstract_inverted_index.net | 107 |
| abstract_inverted_index.the | 113, 140, 152, 237, 259, 281 |
| abstract_inverted_index.two | 88 |
| abstract_inverted_index.was | 92, 165, 195 |
| abstract_inverted_index.0.1% | 63 |
| abstract_inverted_index.0.5% | 57, 162 |
| abstract_inverted_index.66%. | 186 |
| abstract_inverted_index.from | 19, 139, 183 |
| abstract_inverted_index.harm | 18, 91, 190, 238 |
| abstract_inverted_index.have | 32 |
| abstract_inverted_index.life | 97 |
| abstract_inverted_index.plus | 81, 84 |
| abstract_inverted_index.test | 30, 70, 231 |
| abstract_inverted_index.that | 275 |
| abstract_inverted_index.true | 119 |
| abstract_inverted_index.with | 34, 161, 180, 205, 240, 254 |
| abstract_inverted_index.(0.1% | 149 |
| abstract_inverted_index.(TB), | 11 |
| abstract_inverted_index.1,200 | 197 |
| abstract_inverted_index.5,977 | 218 |
| abstract_inverted_index.99.5% | 166 |
| abstract_inverted_index.99.7% | 173 |
| abstract_inverted_index.Brief | 250 |
| abstract_inverted_index.DALYs | 122, 215 |
| abstract_inverted_index.Ultra | 74, 212 |
| abstract_inverted_index.Xpert | 73, 211 |
| abstract_inverted_index.adult | 65 |
| abstract_inverted_index.after | 208, 276 |
| abstract_inverted_index.based | 126 |
| abstract_inverted_index.costs | 271 |
| abstract_inverted_index.false | 22, 116 |
| abstract_inverted_index.harm. | 290 |
| abstract_inverted_index.lower | 133 |
| abstract_inverted_index.ratio | 114 |
| abstract_inverted_index.test, | 280 |
| abstract_inverted_index.times | 198 |
| abstract_inverted_index.using | 174 |
| abstract_inverted_index.value | 111 |
| abstract_inverted_index.would | 135 |
| abstract_inverted_index.years | 98 |
| abstract_inverted_index.(0.25% | 145 |
| abstract_inverted_index.(PPV), | 112 |
| abstract_inverted_index.0.25%, | 61 |
| abstract_inverted_index.common | 14 |
| abstract_inverted_index.global | 59, 153 |
| abstract_inverted_index.health | 270 |
| abstract_inverted_index.higher | 199 |
| abstract_inverted_index.likely | 235, 287 |
| abstract_inverted_index.report | 106 |
| abstract_inverted_index.versus | 219 |
| abstract_inverted_index.within | 87 |
| abstract_inverted_index.(DALYs) | 99 |
| abstract_inverted_index.(median | 217 |
| abstract_inverted_index.(sputum | 79 |
| abstract_inverted_index.100,000 | 160 |
| abstract_inverted_index.3,750). | 220 |
| abstract_inverted_index.Methods | 45 |
| abstract_inverted_index.Results | 131 |
| abstract_inverted_index.against | 75 |
| abstract_inverted_index.averted | 102, 123, 216 |
| abstract_inverted_index.benefit | 223, 282 |
| abstract_inverted_index.burden. | 155 |
| abstract_inverted_index.concern | 15, 253 |
| abstract_inverted_index.crucial | 6 |
| abstract_inverted_index.current | 26, 141 |
| abstract_inverted_index.disease | 85, 175 |
| abstract_inverted_index.finding | 274 |
| abstract_inverted_index.overall | 214 |
| abstract_inverted_index.summary | 251 |
| abstract_inverted_index.through | 94 |
| abstract_inverted_index.years). | 89 |
| abstract_inverted_index.(current | 58 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 25 |
| abstract_inverted_index.adjusted | 96 |
| abstract_inverted_index.clinical | 82 |
| abstract_inverted_index.compared | 200 |
| abstract_inverted_index.coverage | 48, 138, 245 |
| abstract_inverted_index.culture, | 80 |
| abstract_inverted_index.increase | 136 |
| abstract_inverted_index.incurred | 100 |
| abstract_inverted_index.positive | 23, 109, 210, 229, 278 |
| abstract_inverted_index.possible | 241 |
| abstract_inverted_index.relative | 269 |
| abstract_inverted_index.strategy | 7 |
| abstract_inverted_index.Potential | 90 |
| abstract_inverted_index.addition, | 188 |
| abstract_inverted_index.community | 168 |
| abstract_inverted_index.decisions | 41 |
| abstract_inverted_index.different | 76, 128 |
| abstract_inverted_index.estimated | 47, 93, 189 |
| abstract_inverted_index.evaluated | 264 |
| abstract_inverted_index.expanding | 244 |
| abstract_inverted_index.following | 21, 227 |
| abstract_inverted_index.increased | 171 |
| abstract_inverted_index.molecular | 230, 279 |
| abstract_inverted_index.outweighs | 236, 288 |
| abstract_inverted_index.positives | 117 |
| abstract_inverted_index.potential | 17, 260 |
| abstract_inverted_index.providing | 202 |
| abstract_inverted_index.pulmonary | 66 |
| abstract_inverted_index.reference | 27, 77, 129, 178, 266 |
| abstract_inverted_index.screening | 3, 51, 137, 234, 257 |
| abstract_inverted_index.standard, | 179 |
| abstract_inverted_index.standards | 28, 78, 267 |
| abstract_inverted_index.threshold | 55, 134 |
| abstract_inverted_index.treatment | 40, 194, 206, 226, 286 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Discussion | 221 |
| abstract_inverted_index.associated | 239 |
| abstract_inverted_index.considered | 69 |
| abstract_inverted_index.diagnoses. | 24 |
| abstract_inverted_index.diagnostic | 265 |
| abstract_inverted_index.disability | 95 |
| abstract_inverted_index.increasing | 182, 213 |
| abstract_inverted_index.initiating | 284 |
| abstract_inverted_index.initiation | 207 |
| abstract_inverted_index.population | 158 |
| abstract_inverted_index.positives, | 120 |
| abstract_inverted_index.predictive | 110 |
| abstract_inverted_index.prevalence | 37, 54 |
| abstract_inverted_index.screening, | 169 |
| abstract_inverted_index.screening. | 44, 249 |
| abstract_inverted_index.simplified | 247 |
| abstract_inverted_index.standard), | 60 |
| abstract_inverted_index.standards. | 130 |
| abstract_inverted_index.supporting | 243 |
| abstract_inverted_index.threshold) | 146, 150 |
| abstract_inverted_index.thresholds | 38 |
| abstract_inverted_index.treatment, | 204 |
| abstract_inverted_index.treatment. | 104 |
| abstract_inverted_index.appropriate | 193 |
| abstract_inverted_index.determining | 29 |
| abstract_inverted_index.evaluation, | 83 |
| abstract_inverted_index.performance | 31, 71 |
| abstract_inverted_index.prevalence, | 163 |
| abstract_inverted_index.progression | 86, 176 |
| abstract_inverted_index.specificity | 164 |
| abstract_inverted_index.withholding | 192 |
| abstract_inverted_index.implications | 35 |
| abstract_inverted_index.limitations, | 33 |
| abstract_inverted_index.specificity, | 108 |
| abstract_inverted_index.tuberculosis | 10, 256, 285 |
| abstract_inverted_index.approximately | 196 |
| abstract_inverted_index.inappropriate | 203 |
| abstract_inverted_index.overtreatment | 20 |
| abstract_inverted_index.Community-wide | 2 |
| abstract_inverted_index.community-wide | 43, 50, 233, 248, 255 |
| abstract_inverted_index.overtreatment, | 242 |
| abstract_inverted_index.overtreatment. | 262 |
| abstract_inverted_index.(non-)treatment | 125 |
| abstract_inverted_index.(non-)treatment, | 273 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5077644295 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I4210089966 |
| citation_normalized_percentile.value | 0.5109005 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |